Risk of disabling response fluctuations and dyskinesias for dopamine agonists versus levodopa in Parkinsonʼs disease - Haaxma, C A; Horstink, M W; Zijlmans, J C; Lemmens, W A; Bloem, B R; Borm, G F (J Parkinsons Dis, 2015)